Shares of Strides Pharma Science on Friday zoomed over 8 per cent after the company reported a consolidated net profit of Rs 141.91 crore for the September ended quarter.
The scrip climbed 8.23 per cent to close at Rs 372.80 on the BSE. During the day, it advanced 9.68 per cent to Rs 377.80.
On the NSE, it rallied 8 per cent to close at Rs 372.
On traded volume front, 5.07 lakh shares of the company were traded on the BSE and over 63 lakh units on the NSE during the day.
The company had posted a loss of Rs 8.70 crore for the corresponding period of the previous fiscal, Strides Pharma Science said in a BSE filing.
Consolidated total income stood at Rs 728.08 crore for the quarter under consideration as against Rs 529.46 crore for the same period year ago.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app